Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.200
+0.006 (2.88%)
At close: Nov 4, 2024, 4:00 PM
0.196
-0.005 (-2.25%)
After-hours: Nov 4, 2024, 4:56 PM EST
Viracta Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 13.98 | 12.32 | 36.77 | 103.55 | 47.09 | 18.22 | Upgrade
|
| Short-Term Investments | 16.02 | 41.51 | 54.71 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 30.01 | 53.83 | 91.49 | 103.55 | 47.09 | 18.22 | Upgrade
|
| Cash Growth | -58.92% | -41.16% | -11.65% | 119.91% | 158.48% | 353.92% | Upgrade
|
| Other Receivables | - | 0.28 | 0.91 | - | - | - | Upgrade
|
| Receivables | - | 0.28 | 0.91 | - | - | - | Upgrade
|
| Prepaid Expenses | 1.07 | 0.86 | 1.35 | 1.72 | 0.11 | 0.08 | Upgrade
|
| Other Current Assets | - | - | 0.01 | - | - | - | Upgrade
|
| Total Current Assets | 31.07 | 54.96 | 93.75 | 105.27 | 47.2 | 18.3 | Upgrade
|
| Property, Plant & Equipment | 0.21 | 0.46 | 0.41 | 0.88 | 1.03 | 0.12 | Upgrade
|
| Other Long-Term Assets | 0.04 | 1.26 | 1.83 | 2.4 | 0.08 | 0.03 | Upgrade
|
| Total Assets | 31.32 | 56.69 | 95.99 | 108.55 | 48.31 | 18.44 | Upgrade
|
| Accounts Payable | 1.29 | 2.44 | 2.54 | 2.9 | 1.56 | 1.54 | Upgrade
|
| Accrued Expenses | 8.55 | 10.38 | 7.19 | 5.8 | 3.36 | 0.74 | Upgrade
|
| Current Portion of Long-Term Debt | 18.75 | 25.27 | - | - | 1.03 | - | Upgrade
|
| Current Portion of Leases | 0.07 | 0.28 | 0.28 | 0.38 | 0.33 | 0.12 | Upgrade
|
| Total Current Liabilities | 28.65 | 38.37 | 10.01 | 9.08 | 6.28 | 2.39 | Upgrade
|
| Long-Term Debt | - | - | 24.88 | 4.82 | 4.16 | - | Upgrade
|
| Long-Term Leases | - | - | - | 0.28 | 0.66 | - | Upgrade
|
| Total Liabilities | 28.65 | 38.37 | 34.89 | 14.18 | 11.1 | 2.39 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 282.12 | 278.79 | 270.7 | 254.59 | 4.71 | 3.51 | Upgrade
|
| Retained Earnings | -284.9 | -265.93 | -214.87 | -165.68 | -50.92 | -31.9 | Upgrade
|
| Comprehensive Income & Other | -0.01 | 0.01 | -0.18 | - | - | - | Upgrade
|
| Total Common Equity | -2.78 | 12.87 | 55.65 | 88.92 | -46.2 | -28.38 | Upgrade
|
| Shareholders' Equity | 2.67 | 18.32 | 61.1 | 94.37 | 37.21 | 16.05 | Upgrade
|
| Total Liabilities & Equity | 31.32 | 56.69 | 95.99 | 108.55 | 48.31 | 18.44 | Upgrade
|
| Total Debt | 18.82 | 25.56 | 25.16 | 5.48 | 6.18 | 0.12 | Upgrade
|
| Net Cash (Debt) | 11.19 | 28.27 | 66.33 | 98.08 | 40.91 | 18.1 | Upgrade
|
| Net Cash Growth | -76.44% | -57.38% | -32.37% | 139.73% | 126.02% | - | Upgrade
|
| Net Cash Per Share | 0.29 | 0.73 | 1.76 | 3.08 | 125.99 | 7.68 | Upgrade
|
| Filing Date Shares Outstanding | 39.42 | 39.27 | 38.41 | 37.49 | 8.1 | 0.64 | Upgrade
|
| Total Common Shares Outstanding | 39.42 | 39.09 | 38.35 | 37.42 | 8.1 | 0.64 | Upgrade
|
| Working Capital | 2.42 | 16.59 | 83.74 | 96.19 | 40.92 | 15.91 | Upgrade
|
| Book Value Per Share | -0.07 | 0.33 | 1.45 | 2.38 | -5.71 | -44.13 | Upgrade
|
| Tangible Book Value | -2.78 | 12.87 | 55.65 | 88.92 | -46.2 | -28.38 | Upgrade
|
| Tangible Book Value Per Share | -0.07 | 0.33 | 1.45 | 2.38 | -5.71 | -44.13 | Upgrade
|
| Machinery | - | - | - | - | - | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.